메뉴 건너뛰기




Volumn 53, Issue 6, 2012, Pages 1128-1135

EGFR polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI

Author keywords

EGFR tyrosine kinase inhibitor; Lung cancer; Polymorphism

Indexed keywords

ERLOTINIB; GEFITINIB;

EID: 84868117908     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2012.53.6.1128     Document Type: Article
Times cited : (25)

References (24)
  • 2
    • 0012381722 scopus 로고    scopus 로고
    • Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected]
    • Fukuoka M, Yano S, Giaccone G, Tamura T, Nakagawa K, Douillard JY, et al. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected]. J Clin Oncol 2003; 21:2237-46.
    • (2003) J Clin Oncol , vol.21 , pp. 2237-2246
    • Fukuoka, M.1    Yano, S.2    Giaccone, G.3    Tamura, T.4    Nakagawa, K.5    Douillard, J.Y.6
  • 3
    • 4344646459 scopus 로고    scopus 로고
    • Determinants of tumor response and survival with erlotinib in patients with non--small-cell lung cancer
    • Pérez-Soler R, Chachoua A, Hammond LA, Rowinsky EK, Huberman M, Karp D, et al. Determinants of tumor response and survival with erlotinib in patients with non--small-cell lung cancer. J Clin Oncol 2004;22:3238-47.
    • (2004) J Clin Oncol , vol.22 , pp. 3238-3247
    • Pérez-Soler, R.1    Chachoua, A.2    Hammond, L.A.3    Rowinsky, E.K.4    Huberman, M.5    Karp, D.6
  • 4
    • 1842509828 scopus 로고    scopus 로고
    • Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer
    • Miller VA, Kris MG, Shah N, Patel J, Azzoli C, Gomez J, et al. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. J Clin Oncol 2004;22:1103-9.
    • (2004) J Clin Oncol , vol.22 , pp. 1103-1109
    • Miller, V.A.1    Kris, M.G.2    Shah, N.3    Patel, J.4    Azzoli, C.5    Gomez, J.6
  • 5
    • 33646381931 scopus 로고    scopus 로고
    • Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group Study S0126
    • West HL, Franklin WA, McCoy J, Gumerlock PH, Vance R, Lau DH, et al. Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group Study S0126. J Clin Oncol 2006;24:1807-13.
    • (2006) J Clin Oncol , vol.24 , pp. 1807-1813
    • West, H.L.1    Franklin, W.A.2    McCoy, J.3    Gumerlock, P.H.4    Vance, R.5    Lau, D.H.6
  • 6
    • 4444344330 scopus 로고    scopus 로고
    • EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib
    • Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I, et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci U S A 2004; 101:13306-11.
    • (2004) Proc Natl Acad Sci U S A , vol.101 , pp. 13306-13311
    • Pao, W.1    Miller, V.2    Zakowski, M.3    Doherty, J.4    Politi, K.5    Sarkaria, I.6
  • 7
    • 2342471392 scopus 로고    scopus 로고
    • Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
    • Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004;350:2129-39.
    • (2004) N Engl J Med , vol.350 , pp. 2129-2139
    • Lynch, T.J.1    Bell, D.W.2    Sordella, R.3    Gurubhagavatula, S.4    Okimoto, R.A.5    Brannigan, B.W.6
  • 8
    • 19944433797 scopus 로고    scopus 로고
    • The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers
    • Tokumo M, Toyooka S, Kiura K, Shigematsu H, Tomii K, Aoe M, et al. The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers. Clin Cancer Res 2005;11:1167-73.
    • (2005) Clin Cancer Res , vol.11 , pp. 1167-1173
    • Tokumo, M.1    Toyooka, S.2    Kiura, K.3    Shigematsu, H.4    Tomii, K.5    Aoe, M.6
  • 9
    • 45749120442 scopus 로고    scopus 로고
    • Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy
    • Yang CH, Yu CJ, Shih JY, Chang YC, Hu FC, Tsai MC, et al. Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy. J Clin Oncol 2008;26: 2745-53.
    • (2008) J Clin Oncol , vol.26 , pp. 2745-2753
    • Yang, C.H.1    Yu, C.J.2    Shih, J.Y.3    Chang, Y.C.4    Hu, F.C.5    Tsai, M.C.6
  • 11
    • 79960702788 scopus 로고    scopus 로고
    • Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS)
    • Fukuoka M, Wu YL, Thongprasert S, Sunpaweravong P, Leong SS, Sriuranpong V, et al. Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS). J Clin Oncol 2011;29:2866-74.
    • (2011) J Clin Oncol , vol.29 , pp. 2866-2874
    • Fukuoka, M.1    Wu, Y.L.2    Thongprasert, S.3    Sunpaweravong, P.4    Leong, S.S.5    Sriuranpong, V.6
  • 12
    • 79953779287 scopus 로고    scopus 로고
    • Rapid and efficient detection of EGFR mutations in problematic cytologic specimens by high-resolution melting analysis
    • Hlinkova K, Babál P, Berzinec P, Majer I, Ilencikova D. Rapid and efficient detection of EGFR mutations in problematic cytologic specimens by high-resolution melting analysis. Mol Diagn Ther 2011;15:21-9.
    • (2011) Mol Diagn Ther , vol.15 , pp. 21-29
    • Hlinkova, K.1    Babál, P.2    Berzinec, P.3    Majer, I.4    Ilencikova, D.5
  • 14
    • 20444498630 scopus 로고    scopus 로고
    • Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer
    • Cappuzzo F, Hirsch FR, Rossi E, Bartolini S, Ceresoli GL, Bemis L, et al. Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer. J Natl Cancer Inst 2005;97:643-55.
    • (2005) J Natl Cancer Inst , vol.97 , pp. 643-655
    • Cappuzzo, F.1    Hirsch, F.R.2    Rossi, E.3    Bartolini, S.4    Ceresoli, G.L.5    Bemis, L.6
  • 15
    • 34247477205 scopus 로고    scopus 로고
    • Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers
    • Nomura M, Shigematsu H, Li L, Suzuki M, Takahashi T, Estess P, et al. Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers. PLoS Med 2007;4:e125.
    • (2007) PLoS Med , vol.4
    • Nomura, M.1    Shigematsu, H.2    Li, L.3    Suzuki, M.4    Takahashi, T.5    Estess, P.6
  • 16
    • 80051875323 scopus 로고    scopus 로고
    • CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphism
    • Nie Q, Yang XN, An SJ, Zhang XC, Yang JJ, Zhong WZ, et al. CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphism. Eur J Cancer 2011;47:1962-70.
    • (2011) Eur J Cancer , vol.47 , pp. 1962-1970
    • Nie, Q.1    Yang, X.N.2    An, S.J.3    Zhang, X.C.4    Yang, J.J.5    Zhong, W.Z.6
  • 17
    • 11244319884 scopus 로고    scopus 로고
    • A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter
    • Liu W, Innocenti F, Wu MH, Desai AA, Dolan ME, Cook EH Jr, et al. A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter. Cancer Res 2005;65:46-53.
    • (2005) Cancer Res , vol.65 , pp. 46-53
    • Liu, W.1    Innocenti, F.2    Wu, M.H.3    Desai, A.A.4    Dolan, M.E.5    Cook Jr., E.H.6
  • 20
    • 20044364940 scopus 로고    scopus 로고
    • Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
    • Shigematsu H, Lin L, Takahashi T, Nomura M, Suzuki M, Wistuba II, et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 2005;97:339-46.
    • (2005) J Natl Cancer Inst , vol.97 , pp. 339-346
    • Shigematsu, H.1    Lin, L.2    Takahashi, T.3    Nomura, M.4    Suzuki, M.5    Wistuba, I.I.6
  • 21
    • 10844264628 scopus 로고    scopus 로고
    • An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors
    • Amador ML, Oppenheimer D, Perea S, Maitra A, Cusatis G, Iacobuzio-Donahue C, et al. An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors. Cancer Res 2004;64:9139-43.
    • (2004) Cancer Res , vol.64 , pp. 9139-9143
    • Amador, M.L.1    Oppenheimer, D.2    Perea, S.3    Maitra, A.4    Cusatis, G.5    Iacobuzio-Donahue, C.6
  • 22
    • 0037339858 scopus 로고    scopus 로고
    • Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphism
    • Liu W, Innocenti F, Chen P, Das S, Cook EH Jr, Ratain MJ. Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphism. Clin Cancer Res 2003;9:1009-12.
    • (2003) Clin Cancer Res , vol.9 , pp. 1009-1012
    • Liu, W.1    Innocenti, F.2    Chen, P.3    Das, S.4    Cook Jr., E.H.5    Ratain, M.J.6
  • 23
    • 34247281406 scopus 로고    scopus 로고
    • Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer
    • Han SW, Jeon YK, Lee KH, Keam B, Hwang PG, Oh DY, et al. Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer. Pharmacogenet Genomics 2007;17: 313-9.
    • (2007) Pharmacogenet Genomics , vol.17 , pp. 313-319
    • Han, S.W.1    Jeon, Y.K.2    Lee, K.H.3    Keam, B.4    Hwang, P.G.5    Oh, D.Y.6
  • 24
    • 53749106666 scopus 로고    scopus 로고
    • Impact of EGFR gene polymorphisms on anticancer drug cytotoxicity in vitro
    • Puyo S, Le Morvan V, Robert J. Impact of EGFR gene polymorphisms on anticancer drug cytotoxicity in vitro. Mol Diagn Ther 2008;12:225-34.
    • (2008) Mol Diagn Ther , vol.12 , pp. 225-234
    • Puyo, S.1    Le Morvan, V.2    Robert, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.